Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-068011
Filing Date
2024-03-14
Accepted
2024-03-14 17:07:39
Documents
5
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d742385ds8.htm S-8 39062
2 EX-5.1 d742385dex51.htm EX-5.1 6625
3 EX-23.1 d742385dex231.htm EX-23.1 1472
4 EX-FILING FEES d742385dexfilingfees.htm EX-FILING FEES 15565
5 GRAPHIC g742385dsp_7.jpg GRAPHIC 8942
  Complete submission text file 0001193125-24-068011.txt   76407
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277946 | Film No.: 24751200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)